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Background: In Martinique, prostate cancer incidence rates have been increasing since the 1980s and are actually
among the highest worldwide. Exposure to lifestyle (changes in dietary habits), environmental factors (exposure to
organochlorine pesticides) and modifications in diagnostic and screening procedures, are favored etiological
hypotheses. The aim of the present study is to describe and interpret prostate cancer incidence trends over the
past 25 years (1981–2005) in Martinique.
Methods: Data on incident prostate cancer cases from 1981 to 2005 were obtained from the population-based
Martinique Cancer Registry. World age-standardised incidence rates were calculated and an age-period-cohort
model was used to determine average annual variations for prostate cancer during the study period. Age and
period effects were assessed, employing the method proposed by Clayton and Schifflers. Relative changes in
prostate cancer incidence, at five-year intervals between 1981 and 2005, were also studied with an organochlorine
pesticide exposure index, built as a proxy of the relative intensity of chlordecone use on the island between 1973
and 1993.
Results: Prostate cancer incidence was found to increase by 5.07% annually between 1981 and 2005. Compared to
1981–1985, prostate cancer relative risk, in men aged 50–74 years and 75 years and above was respectively 5.98%
and 3.07% from 2001 to 2005. An inverse association between population pesticide exposure levels and prostate
cancer risk was also highlighted, with highest prostate cancer incidences observed in urban zones showing the
lowest soil contamination levels by the chlordecone pesticide (zone 1).
Conclusion: No conclusive association was found between the intensity of pesticide use and the subsequent rise
in prostate cancer incidence. However, it remains necessary to develop and reinforce continuous monitoring of
prostate cancer incidence and mortality trends on the island. Further studies are also needed in order to consider
other risk factors such as modifications in diagnostic and screening procedures over the last 25 years.
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The increasing burden of cancer is becoming more and
more of a public health concern in the French department
of Martinique and is the leading cause of death in men
and women. Over the last decade, the incidences of several
tumors (prostate, breast, colorectal, non-Hodgkin’s lym-
phoma…) have been on the rise in the general population.
Changes in life expectancy and lifestyle habits, as well
as improved diagnostic procedures such as the im-
plementation of screening techniques (mammography,
Prostate Specific Antigen and hemoccult tests) have
been put forward to explain these time trends [1].
Prostate cancer incidence in Martinique is today one
of the highest worldwide [1,2].
In recent years, several studies have aroused public
and scientific concern about the health effects of pesti-
cides. In spite of many publications documenting these
effects, in particular the carcinogenicity of pesticides,
there remains deep controversy over this issue. While
acute effects of pesticides have been well described in
literature, especially with respect to organochlorine poi-
soning, chronic effects of pesticide exposure have been
much more difficult to assess [3].
However, while the natural environment of the French
department is widely recognized as being contaminated
by the substantial use of pesticides due to intensive ba-
nana farming activities [4,5], their role in prostate cancer
etiology has not yet been clearly defined and requires
thorough investigation. Particular questioning remains
about chlordecone- mediated pollution. Chlordecone
(also known as Kepone) is an organochlorine insecticide,
extensively used in Martinique and the rest of the
French West Indies, to control the banana root borer
from 1973 to 1993. The pesticide’s properties (estrogeni-
city, high stability, high persistence in the environment)
has engendered the widespread permanent contami-
nation of soils, river water, wild animals, and vegetables
growing on polluted soils. The latter constitute the
primary source of foodstuff contamination, and hence
remain an indirect source of exposure for local inha-
bitants [4-9].
The aim of the present study is to describe and inter-
prete prostate cancer incidence trends in Martinique
from 1981 to 2005.
Methods
Data on incident prostate cancer cases from 1981 to 2005
were obtained from the population-based Martinique
Cancer Registry. The Registry is a full member of the
International Association of Cancer Registries (IACR).
Data collection and coding are conducted as recom-
mended by the IARC [10].
Registered male cases corresponding to the code C61 (ex-
cluding sarcomas, leukaemia, lymphomas and melanomas)of the International Classification of Diseases for Oncol-
ogy [ICD-O-3] were included. Patient identification num-
ber, date of birth, cancer diagnosis date, histological code
and residential postal code at diagnosis were collected.
Data quality was assessed on the basis of recommen-
dations from the IARC [10]. Each cancer case was
confirmed, on average, by at least two sources (medical
oncology services and private pathology laboratories).
Ninety-five percent of tumors had a microscopic con-
firmation at diagnosis. We furthermore evaluated ex-
haustiveness using the two main data sources by using
“capture-recapture” methods [11]. With case notifications
cross-checked by the use of a wide range of information
sources, the exhaustiveness of the cancer registry was esti-
mated at 97.5%.
Demographic information was collected from the
French National Institute of Statistics and Economic
studies (INSEE), which provides inter-census estimates
of population sizes, as well as data on age and sex distri-
butions for the population of Martinique.
A pesticide exposure index was built by the French Re-
gional Agency for Industry, Research and Environment
(DIREN) to assess cumulative population exposure to
the chlordecone pesticide. This index was built using the
percentage of potentially polluted ground surfaces as a
proxy of the relative intensity of chlordecone use from
1973 to 1993 [12] with four levels of risk of exposure for
the population: none, low, medium and high.
The different municipalities of the island were then
categorized into four zones, according to the pollution
levels by chlodecone: less than 10 percent of chlordecone-
contaminated ground (zone 1), between 10 and 20 percent
(zone 2), between 20 and 30 percent (zone 3) and more
than 30 percent of soil contamination by chlordecone
(zone 4). Areas with high chlordecone contamination
levels (zones 3 and 4) are essentially agricultural rural
areas, while areas with low chlordecone contamination
levels (zones 1 and 2) are essentially urban countries.
World age-standardized incidence rates were calculated
according to 5-year period intervals. A first trend analysis
of trends in prostate cancer incidence between 1981 and
2005 was conducted using an age-period-cohort model to
determine average annual variations (average annual
percent change). Age and period effects were assessed,
employing the method of Clayton and Schifflers [13,14],
with two log-linear Poisson regression models, fitted
separately for (1) age alone and then (2) age and period
(age-drift model). A ‘drift’ parameter, an incidence trend
which can be interpreted as a period effect, was also
computed.
In a second analysis, relative changes in prostate cancer
incidence, in men aged 50 to 74 years and 75 years and
above, were calculated for the 1981–2005 period. Analysis
was stratified according to 5-year period intervals, using
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comparisons of relative prostate cancer risk were also
made by assuming that the observed number of prostate
cancer events followed a Poisson distribution. Relative
changes in prostate cancer incidence were analyzed ac-
cording to diagnosis period and chlordecone exposure
level, using a Poisson Regression model. For all analyses,
prostate cancer cases with missing residential postal codes
at diagnosis were excluded. Significance tests and para-
meter estimations were conducted using the maximum
likelihood method. All analyses were carried out using
SAS 9.2 software [SAS Institute].
Results
Between 1981 and 2005, there were 6097 cases of pros-
tate cancer registered at the Martinique Cancer Registry.
We excluded 404 cases (6.6%) because of missing postal
codes. In the end, 5693 prostate cancer cases were in-
cluded in the study.
The number of prostate cancer cases according to
5-year period intervals, varied from 252 to 2281 newly-
diagnosed cases over the study period. Table 1 details the
age-standardised prostate cancer incidence rates which
increased from 36.9 per 100 000 men-years (period 1981–
1985) to 164 per 100 000 men-years (2001–2005).
Incidence variations according to age
Prostate cancer relative risk, adjusted by age, from 1981
to 2005 (with 1981–1985 as reference period), is pre-
sented in Table 2 for the age groups 50–74 years and
75 years and above. From 1981 to 2005, relative rates for
the disease increased more rapidly in the 50–74 year age
group as compared to 75 year-olds and above. It was
only since 1996 that relative incidence rates for 75 year-
olds and above approximated values registered for 50–
74 year olds a decade earlier (1991).
Incidence variations according to “pesticide exposure”
Relative incidence rates for prostate cancer, adjusted by
age and population pesticide exposure levels between
1981 and 2005, are presented in Table 3. In zone 1 (no
population exposure to chlordecone), relative rates are
found to be statistically significant and increasing fromTable 1 Prostate cancer incidence from 1981 to 2005 in Mart
Period Number of cases Crude inciden
men-years [95
1981-1985 252 40.3 [35.4, 45.3
1986-1990 602 71.5 [65.8, 77.2
1991-1995 964 109 [103, 116]
1996-2000 1594 177 [168, 186]
2001-2005 2281 248 [238, 258]
*95% CI: 95% Confidence Interval.
†World population of 1960 used as standard.1981 to 2005 (p < 0.05 for each study period). As for the
other zones, relative prostate cancer risk was not statis-
tically significant, except for zone 3 where significant
changes in prostate cancer risk were observed between
1996 and 2005.
Discussion
Using data from the Martinique Cancer Registry, we ex-
amined temporal changes in prostate cancer incidence
rates over a 25-year period. During this interval, age-
standardized incidence rates (ASR) for prostate cancer
increased steadily, with an average rise of 5.07% each
year.
On the island, observed incidence variations for this
cancer are slightly lower than observed trends in mainland
France [15], where the average annual increase for pros-
tate cancer was of 5.3% between 1980 and 2005, with
ASRs going from 26 new cases/100 000 men-years in
1980 to 121 new cases/100 000 men-years in 2005. We
also found that prostate cancer incidence variations in
Martinique differed according to age, with relative rates
for the disease increasing more rapidly in 50 to 74 year
olds as compared to 75 year-olds and above.
Since the 1960s, there has been a gradual increase in
the incidence of prostate cancer in many countries. Rea-
sons for these observed international trends are factors
such as population ageing, early diagnosis, introduction of
more sensitive diagnostic procedures, availability of pros-
tate specific antigen screening during the early to mid-
1990s [16,17], and completeness of reporting [16-18].
Moreover, an inverse association between population
pesticide exposure level and prostate cancer risk has
been highlighted by our results, with highest prostate
cancer incidences observed in zones showing the lowest
soil contamination levels by the chlordecone pesticide
(zone 1).
Although differences in incidence for zone 3 were sta-
tistically significant during the periods 1996–2000 and
2001–2005, the magnitude of these differences tends to
be small comparatively to zone 1.
Other arguments exist against a “pesticide effect” in
terms of confounding factors such as population density,
socioeconomic status and differential access to healthinique
ce rate per 100000
% CI]
Age-standardised incidence rate†
per 100000 men-years [95% CI]*
] 36.9 [32.3, 41.5]




Table 3 Relative changes in age-standardised incidence
for prostate cancer, by level of population exposure to
chlordecone, from 1981 to 2005 (reference period:
1981–1985)
Zones* Period RR† 95% CI[ p-value§
1 1981-1985 1.00 - - -.
1986-1990 1.32 1.05 1.67 0.0189
1991-1995 1.72 1.38 2.14 <.0001
1996-2000 2.10 1.69 2.60 <.0001
2001-2005 2.35 1.90 2.91 <.0001
2 1981-1985 1.00 - - -.
1986-1990 0.86 0.63 1.16 0.3174
1991-1995 0.94 0.70 1.24 0.6512
1996-2000 1.01 0.77 1.32 0.9528
2001-2005 1.19 0.91 1.55 0.1960
3 1981-1985 1.00 - - -.
1986-1990 0.89 0.65 1.24 0.5115
1991-1995 1.04 0.77 1.42 0.7801
1996-2000 1.38 1.04 1.84 0.0272
2001-2005 1.59 1.17 2.04 0.0024
4 1981-1985 1.00 - - -.
1986-1990 0.84 0.58 1.22 0.3551
1991-1995 1.16 0.82 1.64 0.3891
1996-2000 1.36 0.97 1.89 0.0696
2001-2005 1.37 0.99 1.89 0.0563
*Zone 1: <10% chlordecone contaminated ground: no population exposure to
chlordecone; Zone 2: 10-20% chlordecone contaminated ground: low population
exposure to chlordecone; Zone 3: 20-30% chlordecone contaminated ground:
medium population exposure to chlordecone; Zone 4: >30% chlordecone contaminated
ground: high population exposure to chlordecone; †RR: Relative risk; [95% CI: 95%
Confidence Interval; §level of significance: p-value < 5%.
Table 2 Relative changes in prostate cancer incidence
from 1981 to 2005 (reference period: 1981–1985)
Age (years) Period RR* [95% CI]† p-value[
50-74 1981-1985 1.00 - - -.
1986-1990 1.86 1.53 2.27 <.0001
1991-1995 2.63 2.18 3.18 <.0001
1996-2000 4.38 3.67 5.24 <.0001
2001-2005 5.98 5.02 7.13 <.0001
> 75 1981-1985 1.00 - - -.
1986-1990 1.62 1.28 2.06 0.0003
1991-1995 2.21 1.77 2.77 <.0001
1996-2000 2.65 2.13 3.29 <.0001
2001-2005 3.07 2.48 3.79 <.0001
*RR: Relative risk; †95% CI: 95% Confidence Interval; [level of significance: p-value < 5%.
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frequently occurs many years after the initial exposure
period [17-19]. In our study, it can thus be imagined that
if the organochlorine pesticide chlordecone was mainly
used during the 1970s-1990s [4,5], a substantial increase
in the number of new prostate cancer cases would have
been reported as from 2000. It can therefore be sup-
posed that elapsed time since initial pesticide exposure
period (1973–1993) may be insufficient to result in
measurable changes in prostate incidence.
A second factor which could explain prostate cancer
patterns on the island is the effect of modifications in
diagnostic procedures. The noted variation in prostate
cancer incidence is higher in 50 to 74 year-olds, who are
the most frequently targeted by early diagnosis and
screening [20]. Our study also showed a significant
period effect (5.07%) which reflects changes in diag-
nostic activities such as PSA testing, as well as improved
registration practices. Indeed, implementations of PSA
testing in the 1990s may have influenced incidence
trends for prostate cancer on the island.
A few limitations are however to be noted in our study.
The first one is regarding the pesticide indicator used to
determine population exposure levels to chlordecone.
Ground contamination represents only one exposure
pathway to pesticides. Exposure routes can be very vari-
able due to the diversity of products used, and changing
professional practices (use of protective material, appli-
cation methods…). Results from the Escal study, targe-
ting the health and eating habits of the population of
Martinique, have however tended to confirm the per-
tinence of the indicator used in our study. This is based
on the hypothesis that in zones with high chlordecone
contamination levels (essentially agricultural rural areas),
residents’ exposure levels were higher, compared to other
urban regions because of a higher contamination through
the food chain [21].A second drawback is the fact that we did not take into
account certain common risk factors which may have con-
tributed partly to the progression of prostate cancer rates
in Martinique. The role of genetic factors, hormonal status
and other environmental factors (dietary, infectious)
should not be downplayed [22-24]. While aging, ethnicity
and a family history of prostate cancer remain the only
well-established risk factors for the disease, environment
and lifestyle related factors are also suspected. On the
island, changes in dietary habits and exposure to organo-
chlorine pesticides are also etiological hypotheses, in
addition to genetics and African ancestry [22,25].
The Karuprostate case–control study in Guadeloupe)
aimed to identify and to characterize genetic and en-
vironmental determinants of prostate cancer onset and
evolution in the French West Indies. One of the specific
objectives was to test whether chlordecone expo-
sure during adulthood, over a 30-year period, favored
the development of prostate cancer [26]. The study’s
findings supported the hypothesis that exposure to
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cancer and suggested that this association may be af-
fected by genetic background, together with environ-
mental agents related to diet or lifestyle [27].
For the geographical analysis of prostate cancer inci-
dence rates according to pesticide exposure, we used
residential postal codes at the time of diagnosis. Inter-
pretation biases, linked to the absence of evaluation of
the residential stability of cancer cases from the sup-
posed time of exposure (1973–1993) to the period of
diagnosis (1981–2005), might also have been introduced
in our study. Moreover, a selection bias is to be sup-
posed as excluded cases, due to missing postal codes,
were older and from the earlier diagnostic groups.
Conclusions
In summary, incidence rates for prostate cancer have
been increasing, in Martinique, over the 25-year study
period at an annual progression rate of 5.07%, reflecting
a period effect. No conclusive association was found bet-
ween the intensity of chlordecone use and the subse-
quent rise in prostate cancer incidence. However, it
remains necessary to develop and reinforce continuous
monitoring of prostate cancer incidence and mortality
trends on the island. Furthermore, well-designed and
well-executed population-based interdisciplinary studies
should help elucidate the independent and combined
effects of environmental and genetic factors, as well as
modifications in diagnostic and screening practice in
prostate cancer etiology.
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